CJC-1295 (with DAC)
CJC-1295 (with DAC) is a growth hormone releasing peptide used in evidence-based, physician-supervised protocols. Use when consistent elevated GH levels are preferred over pulsatile pattern (e.g., tissue repair, fat loss, anti-aging).
What is CJC-1295 (with DAC)?
Same GHRH analogue but with Drug Affinity Complex (DAC) that binds albumin, extending half-life to 6-8 days. Produces sustained GH elevation vs. pulsatile pattern of No-DAC version.
Uses & clinical decision logic
Use when consistent elevated GH levels are preferred over pulsatile pattern (e.g., tissue repair, fat loss, anti-aging). Twice-weekly dosing preferred.
CJC-1295 (with DAC) dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 2mL | 1-2mg | 40-80 units | 1-2x/week | SubQ |
Safety & contraindications
Monitor for GH bleed (elevated IGF-1, water retention, joint aches) — reduce dose if side effects emerge. Active cancer contraindication.
Stacking & combinations
Can combine with Ipamorelin on non-injection days; or use standalone for long-acting GH elevation.
Related peptides
Frequently asked questions
What is CJC-1295 (with DAC) used for?
Use when consistent elevated GH levels are preferred over pulsatile pattern (e.g., tissue repair, fat loss, anti-aging). Twice-weekly dosing preferred.
What is the typical CJC-1295 (with DAC) dosage?
Common dosing ranges from 1-2mg (1-2x/week, SubQ). Exact dosing is individualized and set by a licensed physician.
How is CJC-1295 (with DAC) administered?
CJC-1295 (with DAC) is typically administered via SubQ.
What are the contraindications for CJC-1295 (with DAC)?
Monitor for GH bleed (elevated IGF-1, water retention, joint aches) — reduce dose if side effects emerge. Active cancer contraindication.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.